IBDEI0ZW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17741,0)
 ;;=V58.67^^95^997^27
 ;;^UTILITY(U,$J,358.3,17741,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17741,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,17741,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,17741,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,17742,0)
 ;;=V58.68^^95^997^26
 ;;^UTILITY(U,$J,358.3,17742,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17742,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,17742,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,17742,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,17743,0)
 ;;=V58.69^^95^997^29
 ;;^UTILITY(U,$J,358.3,17743,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17743,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,17743,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,17743,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,17744,0)
 ;;=V58.83^^95^997^50
 ;;^UTILITY(U,$J,358.3,17744,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17744,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,17744,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,17744,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,17745,0)
 ;;=V62.5^^95^997^32
 ;;^UTILITY(U,$J,358.3,17745,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17745,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,17745,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,17745,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,17746,0)
 ;;=V79.1^^95^998^1
 ;;^UTILITY(U,$J,358.3,17746,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17746,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,17746,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,17746,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,17747,0)
 ;;=V61.21^^95^998^8
 ;;^UTILITY(U,$J,358.3,17747,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17747,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,17747,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,17747,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,17748,0)
 ;;=V65.40^^95^998^2
 ;;^UTILITY(U,$J,358.3,17748,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17748,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,17748,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,17748,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,17749,0)
 ;;=V65.42^^95^998^7
 ;;^UTILITY(U,$J,358.3,17749,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17749,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,17749,1,5,0)
 ;;=5^Substance Use/Abuse Counseling
 ;;^UTILITY(U,$J,358.3,17749,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,17750,0)
 ;;=V65.44^^95^998^3
 ;;^UTILITY(U,$J,358.3,17750,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17750,1,2,0)
 ;;=2^V65.44
 ;;^UTILITY(U,$J,358.3,17750,1,5,0)
 ;;=5^HIV Counseling
 ;;^UTILITY(U,$J,358.3,17750,2)
 ;;=^303469
 ;;^UTILITY(U,$J,358.3,17751,0)
 ;;=V65.49^^95^998^5
 ;;^UTILITY(U,$J,358.3,17751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17751,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,17751,1,5,0)
 ;;=5^Oth Specified Counseling
 ;;^UTILITY(U,$J,358.3,17751,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,17752,0)
 ;;=V68.1^^95^998^4
 ;;^UTILITY(U,$J,358.3,17752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17752,1,2,0)
 ;;=2^V68.1
 ;;^UTILITY(U,$J,358.3,17752,1,5,0)
 ;;=5^Issue Repeat Prescription
 ;;^UTILITY(U,$J,358.3,17752,2)
 ;;=^295585
 ;;^UTILITY(U,$J,358.3,17753,0)
 ;;=V70.2^^95^998^6
 ;;^UTILITY(U,$J,358.3,17753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17753,1,2,0)
 ;;=2^V70.2
 ;;^UTILITY(U,$J,358.3,17753,1,5,0)
 ;;=5^Psychiatric Examination
 ;;^UTILITY(U,$J,358.3,17753,2)
 ;;=^295592
 ;;^UTILITY(U,$J,358.3,17754,0)
 ;;=296.20^^95^999^14
 ;;^UTILITY(U,$J,358.3,17754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17754,1,2,0)
 ;;=2^296.20
